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Key learning points 
1. A woman’s journey to a diagnosis of ovarian cancer is often a difficult one.   
2. Treatment and the heavy symptom burden are hard to endure and women 
experience significant levels of psychological distress. 
3. Primary care nurses have a role to play in providing psychological support 
throughout the cancer trajectory, beyond treatment to survivorship. 
 
Introduction 
Ovarian cancer is the sixth most common cancer in women in the UK and the 
most lethal of gynaecological cancers (1). The only proven method of prevention 
is the removal of the ovaries and fallopian tubes before cancer develops. This 
strategy is not recommended for women in the general population, but is 
available for women who are known to be at increased risk of developing ovarian 
cancer because of a genetic predisposition. Ovarian cancer screening aimed at 
reducing mortality through early detection is not available on the NHS, due to 
the lack of a convincing evidence base. 
The generic term ‘ovarian cancer’ encompasses a group of cancers that includes 
the ovaries, along with primary cancers of the fallopian tube and peritoneum. It 
is not a single disease entity but different diseases with different risk factors, 
precursor lesions, patterns of spread, response to chemotherapy and prognosis 
(2, 3). Most patients (80%) present with aggressive high-grade serous 
carcinoma at an advanced stage and overall 5-year survival is less than 35%. 
This poor outcome reflects the high risk of recurrence after initial treatment. The 
psychological impact of this disease can be profound. 
Risk Factors and Presentation 
Healthcare professionals in primary care may only see one or two cases of 
ovarian cancer in their working life. The lifetime risk of ovarian cancer is 2% 
(England, Wales). A woman’s risk of developing ovarian cancer increases with 
age and most occur in women aged 65 years and older. The strongest risk factor 
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is a family history of ovarian cancer and other cancers seen in inherited cancer 
syndromes (breast, bowel). Up to 15% of high-grade serous ovarian cancers are 
associated with a mutation in a tumour suppressor or mismatch repair gene. 
Lifestyle factors that reduce the total number of ovulations, such as use of the 
oral contraceptive pill and breast feeding, are associated with a lower risk. 
Symptoms are non-specific and often mistaken as non-threatening by both 
patients and healthcare providers. Women diagnosed with ovarian cancer often 
have a history of presenting with vague symptoms including fatigue, 
constipation and back pain (4). The GP may have decided on a wait and see 
approach or the patient may have been referred to a non-gynaecological 
oncology specialist for investigation (typically gastrointestinal or bowel). Some 
women report feeling exhausted by the struggle to get a correct diagnosis. NICE 
guidelines list 4 red flag symptoms that may indicate the presence of ovarian 
cancer when experienced persistently or frequently: abdominal bloating, loss of 
appetite, pelvic/abdominal pain, and urinary urgency/frequency (5). 
Diagnosis, Treatment and Management 
The first test for ovarian cancer is the serum CA125 blood test and if the result is 
concerning an abdominal/pelvic ultrasound scan to identify a suspicious mass. If 
ovarian cancer is suspected, women should be urgently referred to a specialist 
centre with expertise in the treatment and management of ovarian cancer, 
where the best outcomes are achieved (6). Formal diagnosis is based on 
cytology or histopathology. 
Over the past 10 years changes in surgical practice aimed at achieving zero 
residual disease and the use of platinum-based chemotherapy treatments have 
led to improvements in survival. Unfortunately while the majority of women 
initially respond well to treatment, most will experience a recurrence of disease 
necessitating repeated surgery and cycles of chemotherapy aimed not at cure, 
but improving the quality of life and palliation.  
Psychological Impact 
The journey to a diagnosis of ovarian cancer is often difficult. It may be abrupt 
following an emergency presentation reflecting advanced disease, or involve a 
protracted struggle for symptoms to be appropriately investigated. The initial 
psychological impact can range from one of shock in women who have been 
unconcerned about non-specific symptoms, to relief at confirmation of the 
reason for symptoms, or disappointment and anger at missed opportunities to 
diagnose the cancer earlier when reported symptoms have been misattributed to 
other less serious conditions and delay may have compromised survival. 
Extensive surgery with major tissue debulking and repetitive cycles of toxic 
chemotherapy are debilitating and challenging to endure. Younger women also 
have to contend with the loss of fertility and a premature menopause. The 
quality of women’s lives is often severely compromised by psychosocial issues 
including personal and family distress at the initial diagnosis, along with fear 
about future diagnostic tests (7). Women may be aware that their doctor is 
expecting the cancer to return and there is uncertainty about when, or if, further 
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treatment will begin. Concomitant psychosexual problems are often not 
addressed and there may be concern that relatives will be diagnosed with cancer 
if there is a heritable component. The prospect of a cure is rare and most face 
the very real possibility of dying (8). Disease progression is often accompanied 
by pain (peripheral neuropathy after intense chemotherapy) and the heavy 
symptom burden can lead to changes in body image (abdominal distention 
caused by ascites), difficulty eating and bowel obstruction, reduced mobility and 
activity, and a loss of confidence leading to social isolation. 
Through all of this, a woman’s cherished relationships come under strain as the 
disease process interferes with her social roles as a mother (particularly if her 
children are young), wife, sister, grandmother and friend. Women face the loss 
of femininity, sexuality, loved ones and the trauma of confronting an early 
death. 
Psychological Support 
Primary care nurses are a potential source of long-term psychological support to 
women diagnosed with ovarian cancer. While input from other specialist 
practitioners may come and go throughout the patient’s cancer journey, the 
primary care nurse remains a constant presence. 
Adjusting to cancer is a normal psychological process that occurs over time as a 
woman and the people she is close to come to understand and adapt to the 
changes caused by the illness and its treatment (9). Inevitably, a life-
threatening diagnosis confronts women with their own mortality. For some, this 
can lead to a period of healthy personal growth with revised priorities and 
lifetime goals. However, maladaptive adjustments (loss of meaning, helplessness 
and despair) can result in a depressive illness or anxiety. Both are common in 
ovarian cancer patients (10), along with a degree of post-traumatic stress 
disorder (11). 
Women should be screened for psychological distress at the beginning of the 
cancer pathway. As part of a Holistic Needs Assessment and Care Plan (12) 
women complete a brief assessment checklist at strategic points along the 
cancer trajectory, highlighting issues causing the greatest distress and 
immediate support needs. This may prompt further evaluation by a psychology 
member of the clinical team or clinical nurse specialist. Self-report measures, 
such as the Hospital Anxiety and Depression Scale (HADS) (13), are used to 
identify women requiring specialist input from a psychologist or counsellor 
(trauma focused cognitive behavioural therapy, mindfulness stress reduction). 
More women are surviving and living beyond cancer and their psychological 
wellbeing is an integral part of a survivorship care plan. The primary care nurse 
is at the heart of this process (14) offering proactive advice to enhance 
emotional support and practical strategies for dealing with stress and low mood, 
difficulty sleeping, lethargy and a lack of concentration. Encouraging women to 
set goals for the future can restore a measure of self-control that is integral to a 
sense of security and self-esteem. The simple step of signposting women on to 
further sources of information (Cancer Research UK, Citizens Advice Bureau) and 
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support (Relate, and charity-run helplines for ovarian cancer) can also be 
helpful. 
A one size fits all approach to any intervention which fails to address women’s 
innate preferences for emotional support in response to a life-threatening illness 
is unlikely to achieve the maximum benefit (15). Early experiences of receiving 
emotional support during infancy form a template for preferences in later adult 
life. Individuals can be broadly categorized as secure (60% of the population) or 
insecure in their willingness to seek support. The securely attached feel 
comfortable asking for support in the confident expectation it will be given. This 
contrasts with the insecurely anxious who crave support but worry it will not be 
forthcoming, and the insecurely avoidant who feel most comfortable with 
emotional distance and self-reliance. More anxiously attached women may 
welcome frequent short contact and an opportunity for intense emotional 
expression. The compulsively self-reliant avoidant woman may feel more 
comfortable with interpersonal distance and less frequent contact perhaps by 
telephone rather than face-to-face. Being sensitive to these differences and 
tailoring psychological interventions to address them is likely to be most 
effective (16). 
Primary care nurses play a key role in linking the support and care provided by 
GP practices and hospital-based oncology and palliative care services, along with 
coordinating community based services. Developing a consistent approach to 
managing the psychological impact of ovarian cancer can be achieved through 
good communication amongst healthcare professionals working as a team and 
sharing insights into patients’ support needs.  
What the Future Holds 
Managing the consequences of cancer and its treatment in primary care is set to 
increase in an ageing population.  Primary care nurses will need to undergo 
education and training, to enable them to fulfil this changing role.  The 
Macmillan toolkit is a useful online resource (www.rcgp.org.uk/coc).  A body of 
research is developing that will provide the evidence base to design clinical 
practice guidelines on psychological interventions (17). It is hoped that this 
work, along with a better understanding of the sub-types of ovarian cancer and 
progress in biomarker discovery, will lead to improvements in earlier diagnosis, 
improved survival, and a better quality of life for those affected by ovarian 
cancer.  
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